Joan W. Miller, MD, has been appointed to the Association of University Professors of Ophthalmology (AUPO) Board of Trustees. As Chair of Harvard Ophthalmology since 2003, Dr. Miller is committed...
Regulating transcription factor RUNX1 using small molecule drugs a promising novel therapy for diseases of the retina, including advanced diabetic eye disease.
Yoshihiro Yonekawa, MD, was included in The Ophthalmologist’s 2017 Power List. This list is created by the magazine’s leadership, who vote for ophthalmology’s top 50 rising stars. Dr. Yonekawa joined...